The total return over the past 12 months is +11.55% vs. +16.94% for the S&P 500. So far it's up +5.20% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +5.10% | +11.17% | +5.55% | (2.18%) | +5.31% | (0.18%) |
| Total Return CAGR | +11.55% | +19.19% | +14.18% | +6.05% | +13.66% | +5.95% |
| Revenue CAGR | +17.26% | +16.65% | +14.13% | +12.55% | +34.78% | N/A |
| Net Income CAGR | (64.11%) | N/A | N/A | +1.35% | +22.54% | N/A |
| EPS CAGR | (66.15%) | N/A | (0.91%) | (5.36%) | +5.42% | N/A |
| Free Cash Flow CAGR | +2.23% | +3.25% | +1.93% | +7.75% | +30.27% | N/A |
| Operating Cash Flow CAGR | +9.66% | +5.70% | +1.88% | +8.50% | +30.27% | N/A |
| Dividends CAGR | 0.00% | 0.00% | (2.33%) | (2.84%) | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Sabra Health Care REIT, Inc. (SBRA)
| Year | Start price | End price | SBRA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $18.94 | $19.07 | +5.20% | +14.51% | (9.31%) |
| 2025 | $17.32 | $18.94 | +16.90% | +17.72% | (0.82%) |
| 2024 | $14.27 | $17.32 | +31.16% | +24.89% | +6.27% |
| 2023 | $12.43 | $14.27 | +26.18% | +26.19% | (0.01%) |
| 2022 | $13.54 | $12.43 | +0.45% | (18.17%) | +18.62% |
| 2021 | $17.37 | $13.54 | (16.18%) | +28.74% | (44.92%) |
| 2020 | $21.34 | $17.37 | (11.47%) | +18.37% | (29.84%) |
| 2019 | $16.48 | $21.34 | +41.08% | +31.22% | +9.86% |
| 2018 | $18.77 | $16.48 | (3.63%) | (4.56%) | +0.93% |
| 2017 | $24.42 | $18.77 | (16.86%) | +21.70% | (38.56%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
